Cardiac and aerobic response to growth hormone therapy in children with short stature: a prospective study using VO2max and speckle tracking echocardiography - Takeaways - MDSpire

Cardiac and aerobic response to growth hormone therapy in children with short stature: a prospective study using VO2max and speckle tracking echocardiography

  • By

  • Ignacio Ruiz del Olmo-Izuzquiza

  • Antonio de Arriba-Muñoz

  • Lorenzo Jiménez-Montañés

  • Ángel Matute-Llorente

  • Marta Vara-Callau

  • Marta Ferrer-Lozano

  • José-Antonio Casajús-Mallén

  • José-Ignacio Labarta-Aizpún

  • May 28, 2026

  • 0 min

Share

  • 1

    The study evaluated the effects of recombinant human growth hormone (r-hGH) on aerobic capacity and cardiac function in short-statured prepubertal children.

  • 2

    Thirty children participated, including 18 with growth hormone deficiency (GHD) and 12 non-GHD, receiving r-hGH for 12 months.

  • 3

    r-hGH therapy significantly increased IGF-1 levels and left ventricular mass indices, but VO2max showed no overall improvement.

  • 4

    GHD children, particularly girls, experienced a significant decrease in VO2max despite high adherence to therapy.

  • 5

    Speckle tracking echocardiography revealed early improvements in myocardial contractility in GHD patients, although GLS remained unchanged.

Original Source(s)

Related Content